National Health Determination under paragraph 98C(1)(b) Amendment 2016 (No. 4) (PB 44 of 2016) (Cth)

PB 44 of 2016

National Health Determination under paragraph 98C(1)(b) Amendment 2016
(No. 4)
_____________________________________________________________________

I, PENNY SHAKESPEARE, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under paragraph 98C(1)(b) of the National Health Act 1953.

Dated            27^th May 2016

PENNY SHAKESPEARE
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health

1              Name of Instrument

(1)This Instrument is the National Health Determination under paragraph 98C(1)(b) Amendment 2016 (No. 4).

(2)This Instrument may also be cited as PB 44 of 2016.

2              Commencement  

This instrument commences on 1 June 2016.

3              Amendments to Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)

Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).

Schedule 1            Amendments

1. Schedule 3, entry for Fentanyl in each of the forms: Tablet (orally disintegrating) 100 microgram (as citrate); Tablet (orally disintegrating) 200 microgram (as citrate); Tablet (orally disintegrating) 400 microgram (as citrate); Tablet (orally disintegrating) 600 microgram (as citrate);and Tablet (orally disintegrating) 800 microgram (as citrate)

   omit from the column headed “Form (strength, type, size, etc.)”:             microgram
   substitute:             micrograms